Bank of New York Mellon’s PAVmed PAVM Stock Holding History

Bank of New York Mellon’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-78	Closed	-$10.3K	–	4365
2023 Q3	$10.3K	Sell	78 -151	-66%	-$23.4K	﹤0.01%	4294
2023 Q2	$42K	Sell	229 -1	-0.4%	-$200	﹤0.01%	4203
2023 Q1	$38.7K	Hold	230	–	–	﹤0.01%	4240
2022 Q4	$49.7K	Buy	230 +69	+43%	+$26.1K	﹤0.01%	4238
2022 Q3	$62K	Buy	161 +83	+106%	+$47K	﹤0.01%	4290
2022 Q2	$33K	Sell	78 -391	-83%	-$189K	﹤0.01%	4434
2022 Q1	$278K	Hold	469	–	–	﹤0.01%	4051
2021 Q4	$519K	Sell	469 -369	-44%	-$802K	﹤0.01%	3790
2021 Q3	$3.22M	Buy	838 +43	+5%	+$136K	﹤0.01%	2727
2021 Q2	$2.29M	Buy	795 +431	+118%	+$1.02M	﹤0.01%	2900
2021 Q1	$726K	Buy	364 +106	+41%	+$159K	﹤0.01%	3501
2020 Q4	$245K	Buy	258 +79	+44%	+$67.6K	﹤0.01%	3906
2020 Q3	$144K	Hold	179	–	–	﹤0.01%	3917
2020 Q2	$170K	Buy	+179	New	+$179K	﹤0.01%	3835

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.37B AUM 28.49% 1-Year Est. Return

Bank of New York Mellon's PAVM Position: Q4 2023 in Review

Bank of New York Mellon sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 78 shares — an estimated $10.3K sold.

Bank of New York Mellon first reported a position in PAVM in Q2 2020 and held it in 14 quarters. The position peaked at $3.22M in Q3 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

Bank of New York Mellon reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
Bank of New York Mellon sold 78 PAVmed shares in Q4 2023, an estimated $10.3K.
Bank of New York Mellon first reported a position in PAVmed in Q2 2020 and held it in 14 quarters.
Bank of New York Mellon's PAVmed position peaked at $3.22M in Q3 2021.
23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.